GIA announces the release of a comprehensive global report on Huntington’s Disease Therapeutics. The global market for Huntington’s Disease Therapeutics is projected to exceed US$1.3 billion by 2020, driven by growing awareness about the disease worldwide and the huge unmet patient needs.
(PRWeb March 20, 2015)
Read the full story at http://www.prweb.com/releases/xenazine_market_sales/tetrabenazine_market/prweb12598245.htm
For more information, please visit
http://www.prweb.com/releases/xenazine_m[...]azine_market/prweb12598245.htm